Marvell: Koopmans trust proposes $1.87M share sale
The notice lists a 10,000-share sale and three prior 10,000-share sales dated August, September, and October 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Marvell Technology, Inc. is named as issuer in a notice reporting that the Koopmans Family Trust U/A DTD 03/28/2013 proposes to sell 10,000 common shares with an aggregate market value of $1,869,674. Morgan Stanley Smith Barney LLC is named as broker, and November 2, 2026 is the approximate sale date. The form lists “Officer” in the relationship-to-issuer field and is signed by Chris Koopmans.
The remarks state that the shares to be sold were acquired upon vesting of restricted stock and Performance Shares from April 15 through October 15, 2026. The past-three-months table lists three 10,000-share sales by the trust: October 1, 2026, for $2,620,515; September 1, 2026, for $2,032,703; and August 3, 2026, for $1,805,004.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.